Nurix
Ge Peng has a work experience spanning over two decades. Starting in 1996, they worked as a Senior Scientist at Novartis before moving on to GSK-Affymax Research Institute as a Staff Scientist. In 2000, they became a Principal Investigator at XenoPort Inc, where they stayed until 2010. From 2012 to 2015, Ge Peng worked as a Senior Scientist II at Onyx Pharmaceuticals. They then joined Nurix Therapeutics in 2016, first as a Senior Scientist in Medicinal Chemistry and later as a Principal Scientist in the same field.
Ge Peng completed a PhD in Chemistry from Rice University from 1991 to 1996. Prior to that, Ge Peng attended Nankai University, but no specific degree or field of study information is available.
This person is not in any offices
Nurix
3 followers
Nurix Therapeutics discovers drugs that harness the body's natural process to control protein levels. Nurix is focused on developing drugs to treat cancer including the novel, small molecule immuno-oncology agents.